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Abstract
Background: Silibinin, a natural polyphenolic flavonoid, has been reported to induce cell death in various cancer
cell types. However, the molecular mechanism is not clearly defined. Our previous study showed that silibinin
induces glioma cell death and its effect was effectively prevented by calpain inhibitor. The present study was
therefore undertaken to examine the role of calpain in the silibinin-induced glioma cell death.
Methods: U87MG cells were grown on well tissue culture plates and cell viability was measured by MTT assay. ROS
generation and △ψm were estimated using the fluorescence dyes. PKC activation and Bax expression were
measured by Western blot analysis. AIF nuclear translocation was determined by Western blot and
immunocytochemistry.
Results: Silibinin induced activation of calpain, which was blocked by EGTA and the calpain inhibitor Z-Leu-Leu-
CHO. Silibinin caused ROS generation and its effect was inhibited by calpain inhibitor, the general PKC inhibitor GF
109203X, the specific PKCδ inhibitor rottlerin, and catalase. Silibinin-induce cell death was blocked by calpain
inhibitor and PKC inhibitors. Silibinin-induced PKCδ activation and disruption of △ψm were prevented by the calpain
inhibitor. Silibinin induced AIF nuclear translocation and its effect was prevented by calpain inhibitor. Transfection
of vector expressing microRNA of AIF prevented the silibinin-induced cell death.
Conclusions: Silibinin induces apoptotic cell death through a calpain-dependent mechanism involving PKC, ROS,
and AIF nuclear translocation in U87MG human glioma cells.
Background
Glioblastoma is the most lethal and frequent primary
brain tumors [1]. It is comprised of poorly differentiated
heterogeneous neoplastic astrocytes with aggressive pro-
liferation and highly invasive properties. After diagnosis
of glioblastoma, the median survival time of 9-12
months has remained unchanged despite aggressive
treatment including surgery, radiation, and chemother-
apy [2,3]. Thus, new effective strategies for controlling
glioblastoma are required. Because glioblastoma cells
avoid differentiation and apoptosis, the induction of dif-
ferentiation and apoptosis in glioblastoma cells may be
considered as a potential treatment strategy.
Silibinin, a natural polyphenolic flavonoid, is a major
bioactive component of silymarin which is isolated from
the plant milk thistle (Silybum marianum), and has
been extensively used for its hepatoprotective effects in
Asia and Europe. It has been reported that silibinin has
anticancer activities in various cancers including pros-
tate cancer in both in vitro and in vivo models [4-7].
Recently, we observed that silibinin induces apoptosis
through Ca
2+/ROS-dependent mechanism in human
glioma cells [8]. The study showed that silibinin-induced
cell death was prevented by calpain inhibitor, suggesting
involvement of calpain activation in apoptosis induced
by silibinin. Therefore, the present study was undertaken
to examine role of calpain in the sililbinin-induced
glioma cell death. The present study demonstrated that
silibinin induces human glioma cell death via a calpain-
dependent AIF nuclear translocation involving ROS and
PKC.
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Reagents
Silibinin, GF 109203X, rottlerin, catalase, MTT, propi-
dium iodide was purchased from Sigma-Aldrich Chemi-
c a l( S t .L o u i s ,M O ,U S A ) .Z - L e u - L e u - C H Ow a s
purchased from BIOMOL International LP (Plymouth
Meeting, PA, USA). DCFH-DA and DiOC6(3) were
obtained from Molecular Probes (Eugene, OR, USA).
Antibodies were obtained from Cell Signaling Technol-
ogy Inc. (Beverly, MA, USA). All other chemicals were
of the highest commercial grade available.
Cell culture
U87MG cells were obtained from the American Type
Culture Collection (Rockville, MD, USA) and maintained
by serial passages in 75-cm
2 culture flasks (Costar, Cam-
bridge, MA, USA). The cells were grown in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco BRL, Invitro-
gen, Carsbad, CA, USA) containing 10% heat inactivated
fetal bovine serum (HyClone, Logan, UT, USA) at 37°C
in humidified 95% air/5% CO2 incubator. When the cul-
tures reached confluence, subculture was prepared using
a 0.02% EDTA-0.05% trypsin solution. The cells were
grown on well tissue culture plates and used 1-2 days
after plating when a confluent monolayer culture was
achieved. Unless otherwise stated, cells were treated with
silibinin in serum-free medium. Test reagents were
added to the medium 30 min before silibinin exposure.
Measurement of cell viability
Cell viability was evaluated using a MTT assay [9]. Cul-
ture medium containing 0.5 mg/ml of MTT was added
to each well. The cells were incubated for 2 h at 37°C,
the supernatant was removed and the formed formazan
crystals in viable cells were solubilized with 0.11 ml of
dimethyl sulfoxide. A 0.1 ml aliquot of each sample was
then translated to 96-well plates and the absorbance of
each well was measured at 550 nm with ELISA Reader
(FLUOstar OPTIMA, BMG LABTECH, Offenburg, Ger-
many). Data were expressed as a percentage of control
measured in the absence of silibinin.
Measurement of calpain activity
Calpain activity was measured by calpain assay kit (Bio-
Vision Research Products, CA, USA) according to the
manufacturer’si n s t r u c t i o n s .C e l l sw e r eg r o w ni n6 - w e l l
plates and were treated as indicated. Detached cells from
the bottom of culture plates by trypsin were pelleted by
centrifugation and washed with phosphate-buffered sal-
ine (PBS). The pellet were suspended in extraction buffer
and incubated on ice for 20 min then centrifuged at
10,000 × g for 10 min at 4°C. The supernatant repre-
sented the cytosolic protein. Add 10 μl of 10× reaction
buffer and 5 μl of calpain substrate, Ac-LLY-AFC, to
each assay. Incubate at 37°C for 1 h in the dark. After
incubation, production of free AFC was fluorometrically
measured suing a Victor 3 Multilabel Counter with an
excitation filter of 400 nm and an emission filter of 505
nm (PerkinElmer, Boston, MA, USA).
Measurement of reactive oxygen species (ROS)
The intracellular generation of ROS was measured using
DCFH-DA. The nonfluorescent ester penetrates into the
cells and is hydrolyzed to DCFH by the cellular
esterases. The probe (DCFH) is rapidly oxidized to the
highly fluorescent compound DCF in the presence of
cellular peroxidase and ROS such as hydrogen peroxide
or fatty acid peroxides. Cells cultured in 24-well plate
were preincubated in the culture medium with 30 μM
DCFH-DA for 1 h at 37°C. After the preincubation, the
cells were exposed to 30 μM silibinin for various times.
Changes in DCF fluorescence was assayed using FAC-
Sort Becton Dickinson Flow Cytometer (Becton-Dickin-
son Bioscience, San Jose, CA, USA) and data were
analyzed with CELLQuest Software.
Measurement of △ψm
The △ψm was measured with DiOC6(3), a fluorochrome
that is incorporated into cells depending upon the mito-
chondrial membrane potential [10]. Loss in DiOC6(3)
staining indicates disruption of the △ψm.C e l l sw e r e
stained with DiOC6(3) at a final concentration of 50 nM
for 20 min at 37°C in the dark. Cells were washed and
resuspended in Hank’s balanced salts solution containing
Ca
2+ and Mg
2+. The fluorescence intensity was analyzed
with a FACScan flow cytometer using the fluorescence
signal 1 channel.
Western blot analysis
Cells were harvest at various times after silibinin treatment
and disrupted in lysis buffer (1% Triton X-100, 1 mM
EGTA, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4). Cell deb-
ris was removed by centrifugation at 10,000 g for 10 min
at 4°C. The resulting supernatants were resolved on a 10%
SDS-PAGE under denatured reducing conditions and
transferred to nitrocellulose membranes. The membranes
w e r eb l o c k e dw i t h5 %n o n - f a td r i e dm i l ka tr o o mt e m -
perature for 30 min and incubated with different primary
antibodies. The membranes were washed and incubated
with horseradish peroxidase-conjugated secondary antibo-
dies. The signal was visualized using an enhanced chemi-
luminescence (Amersham, Buckinghamshire, UK).
Measurement of AIF nuclear translocation
Cells were harvested and washed twice with PBS. The cells
were incubated with extraction buffer (10 mM Hepes,
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EDTA, 1 mM EGTA, 0.05% digitonin, and 1 mM phenyl-
methylsulfonyl fluoride) at 4°C for 10 min, then centri-
fuged at 100000 g for 10 min at 4°C. The supernatant
cytosolic protein was removed and the pellet was incu-
bated in the nuclear extraction buffer (350 mM NaCl, 1
mM EGTA, 1 mM EDTA, 10 mM Tris-HCl, pH 7.4, and
protease inhibitors) at 4°C for 10 min, then centrifuged at
10000 g for 10 min at 4°C. Proteins were loaded onto a
12% SDS-polyacrylamide gels and transferred to nitrocel-
lulose membranes. After blocking in 5% non-fat dried
milk at room temperature for 30 min, membranes were
probed with rabbit polyclonal anti-AIF antibody, followed
by horseradish peroxidase-conjugated secondary antibo-
dies. Bands were visualized using the ECL detection sys-
tem (Amersham, Buckinghamshire, UK).
AIF nuclear translocation was further confirmed by
immunofluorescence analysis. Cells were cultured on
glass coverslips and treated with silibinin. Cells were
washed twice with PBS, fixed with 4% paraformadehyde
in PBS for 10 min, permeabilized with 0.5% Triton X-
100 in PBS for 10 min. After washing twice with PBS,
cells were blocked with 8% BSA in Tris-buffered saline
Triton X-100 (TBST). Cells were incubated with rabbit
polyclonal anti-AIF overnight 4°C and washed twice
with TBST. Cells were incubated with FITC-conjugated
secondary antibody (Jackson ImmunoResearch Labora-
tories, PA, USA) for 1 h, and the nuclei were counter-
stained with propidium iodide to ascertain AIF unclear
localization. Cell were washed twice and visualized by
using the confocal microscope (Leica, Wetzlar,
Germany).
RNA interference (RNAi)
For AIF targeting, we used The BLOCK-iT™ Pol miR
RNAi Expression Vector Kits (Invitrogen, Carlsbad, CA,
USA) to facilitate the expression of microRNA (miRNA).
miRNA sequences for AIF were designed using online
software (BLOCK-iT RNAi Designer from Invitrogen).
T h et a r g e ts e q u e n c ew a s5 ’-GTGCCTATGCCTACAA-
GACTA-3’. This single-stranded oligonucleotide gener-
ated a double-stranded oligonucleotide, which instructed
into pcDNA™ 6.2-GW/EmGFP-miR vector. This vector
contains EmGFP that allow identifying of the transfection
efficiency using fluorescence microscopy. The construct
pcDNA™ 6.2-GW/EmGFP-miR-LacZ was used as a con-
trol. Cells were transiently transfected with these plas-
mids using lipofectamine (Invitrogen).
Statistical analysis
The data are expressed as means ± SEM and the differ-
ence between two groups was evaluated using Student’s
t-test. Multiple group comparison was done using one-
way analysis of variance followed by the Tukey post hoc
test. A probability level of 0.05 was used to establish
significance.
Results and Discussion
Effect of calpain inhibitor on silibinin-induced cell death
Calpains are cytosolic Ca
2+-activated neutral cysteine
proteases and ubiquitously distributed in all animal
cells, which play a critical role in regulating cell viability
[11,12]. Accumulating evidence suggests that calpain
activation may contribute to cell death in certain cell
types including thymocytes, monocytes, cardiomyocytes,
and neuronal cells [13]. Since our previous study
showed that the calpain inhibitor Z-Leu-Leu-CHO at
0.5 μM significantly protected effectively against the sili-
binin-induced cell death [8], we observed in the present
study the dose-dependency of the inhibitor effect. The
results showed that the calpain inhibitor exerted protec-
tive effect against the silibinin-induced cell death in a
dose-dependent manner with maximum potency at 0.5-
1 μM (Figure 1A). Silibinin also induced calpain activa-
tion, which was blocked by EGTA and calpain inhibitor
(Figure 1B). These results indicate that calpain activation
plays a critical role in the silibinin-induced cell death in
human glioma cells.
Role of calpain and protein kinase C (PKC) activation in
ROS generation and cell death induced by silibinin
The silibinin-induced cell death was associated with
ROS generation mediated by intracellular Ca
2+ [8]. To
determine therefore whether ROS production by silibi-
nin is attributed to calpain activation, cells were exposed
to silibinin in the presence of calpain inhibitor and ROS
generation was measured. As shown in Figure 2A, the
silibinin-induced ROS generation was blocked by the
calpain inhibitor with potency similar to that of catalase.
PKCs are a family of serine/threonine kinases which are
involved in tumor formation and progression [14]. PKC
isoforms cooperate or exert opposite effects on the process
of apoptosis [15,16]. PKC isoforms such as PKCa, ε,a n dξ
inhibit apoptosis, whereas PKCδ is involved in the process
of apoptosis [16,17]. Although previous studies have
shown that flavonoids can induce activation of PKC
[18,19], it is unclear whether PKC is involved in the signal-
ing cascade of silibinin-induced cell death. Although PKCs
are activated by ROS [20,21], it has been reported that
PKC activation can also cause ROS generation [22,23].
Therefore, we examined involvement of PKC in the silibi-
nin-induced ROS generation. The general PKC inhibitor
GF 109203X and the selective PKCδ inhibitor rottlerin
blocked the ROS generation (Figure 2A). The silibinin-
induced cell death was also prevented by the general PKC
inhibitor GF 109203X and rottlerin (Figure 2B), indicating
that silibinin induces ROS generation and cell death
through PKC activation. We next examined whether
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Page 3 of 8silibinin induces PKCδ phosphorylation, an index of PKCδ
activation. Silibinin induced a transient phosphorylation of
PKCδ after 10 min of treatment, which was inhibited by
treatment of calpain inhibitor (Figure 2C and 2D), suggest-
ing that PKCδ may be a downstream of calpain in the sili-
binin-induced cell death. Similar results are reported in
human U-937 leukemia cells in which the flavonoid wogo-
nin induces cell arrest through PKCδ activation [18].
Role of Bax expression and mitochondria in silibinin-
induced cell death
Since numerous death signals converge on mitochondria
through the activation of pro-apoptotic members of the
Bcl-2 family such as Bax [24], calpain activation may
induce the silibinin-induced cell death through a Bax-
dependent pathway. To test this possibility, the effect of
silibinin on Bax expression was examined. Silibinin
increased Bax expression after 3 h of treatment, which
was blocked by the calpain inhibitor (Figure 3).
The increase in Bax expression may cause disruption
of △ψm to induce cell death. To test the possibility, cells
were exposed to silibinin and the △ψm was measured
using the fluorescence dye. After silibinin treatment, dis-
ruption of △ψm was observed as evidenced by an
increase in the proportion of cells with lower fluores-
cence intensity (Figure 4A). The reduction in △ψm was
observed after 3 h of silibinin treatment and remained
unchanged even after 12 h (Figure 4B).
Disruption of △ψm by silibinin may be associated with
ROS generation. To test the possibility, cells were
exposed to silibinin in the presence of the antioxidant
catalase and △ψm was measured. Figure 4C shows that
the silibinin-induced reduction in △ψm was blocked by
catalase, suggesting that the △ψm disruption by silibinin
is mediated by ROS generation.
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Figure 1 Role of calpain in silibinin-induced cell death. (A) Cells
were exposed to 30 μM silibinin for 36 h in the presence of various
concentrations of calpain inhibitor (Z-CHO). Cell viability was
estimated by MTT assay. Data are mean ± SEM of four independent
experiments performed in duplicate. *p < 0.05 compared with
silibinin alone. (B) Cells were exposed to 30 μM silibinin for 24 h in
the presence of 2 mM EGTA and 0.5 μM Z-CHO. Calpain activity was
measured by calpain assay kit. Data are mean ± SEM of four
independent experiments performed in duplicate. *p < 0.05
compared with silibinin alone.
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Figure 2 Role of calpain and PKC in ROS generation and cell
death induced by silibinin. (A) Effect of inhibitors of calpain and
PKC on silibinin-induced ROS generation. Cells were exposed to 30
μM silibinin in the presence or absence of 0.5 μM calpain inhibitor
(CHO), 1 μM GF 109203X (GF), 1 μM rottlerin (Ro), and 800 units/ml
catalase (Cat) and ROS generation was estimated by measuring
changes in DCF fluorescence using FACS analysis. Data are mean ±
SEM of five independent experiments performed in duplicate. *p <
0.05 compared with silibinin alone. (B) Effect of PKC inhibitors on
silibinin-induced cell death. Cells were exposed to 30 μM silibinin in
the presence or absence of 1 μM GF 109203X (GF) and 1 μM
rottlerin (Ro) and cell viability was measured by MTT assay. Data are
mean ± SEM of four independent experiments performed in
duplicate. *p < 0.05 compared with silibinin alone. (C) Effect of
silibinin on PKCδ activation. Cells were exposed to 30 μM silibinin
for various times and PKCδ phosphorylation was estimated by
Western blot analysis. (D) Effect of calpain inhibitor on PKCδ
phosphorylation. Cells were exposed to 30 μM silibinin for 10 min in
the presence or absence of 0.5 μM calpain inhibitor (CHO) and PKCδ
phosphorylation was estimated by Western blot analysis.
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Page 4 of 8As shown above, since the silibinin-induced ROS gen-
eration was blocked by inhibitors of calpain and PKC, the
silibinin-induced disruption of △ψm would be prevented
by these inhibitors. As expected, the reduction in △ψm was
blocked by Z-Leu-Leu-CHO, GF 109203X, and rottlerin,
with similar potency to that by catalase (Figure 4C).
Role of AIF nuclear translocation in silibinin-induced cell
death
The mitochondrial apoptotic pathway is initiated by
the cytosolic release of mitochondrial intermembrane
space proteins that can trigger either caspase-activation
or caspase-independent apoptotic pathways [25,26].
Mitochondrial proteins that cause caspase-dependent
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Figure 3 Effect of silibinin on Bax expression. Cells were
exposed to 30 μM silibinin for various times and Bax expression was
estimated by Western blot analysis. Representative (A) and
quantitative (B) results of four independent experiments. (C) Cells
were exposed to 30 μM silibinin for 24 h in the presence or
absence of 0.5 μM calpain inhibitor (CHO) and Bax expression was
estimated by Western blot analysis.
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Figure 4 Effect of silibinin on mitochondrial membrane
potential (MMP). Cells were exposed to 30 μM silibinin for 6 h (A)
and various times (B). The MMP was estimated by the uptake of a
membrane potential-sensitive fluorescence dye DiCO6(3). The
fluorescence intensity was analyzed using FACS analysis. Data in (B)
are mean ± SEM of three independent experiments performed in
duplicate. *p < 0.05 compared with control. (C) Effect of inhibitors
of calpain and PKC and antioxidant on silibinin-induced disruption
of MMP. Cells were exposed to 30 μM silibinin for 6 h in the
presence or absence of 0.5 μM calpain inhibitor (CHO), 1 μMG F
109203X (GF), 1 μM rottlerin (Ro), and 800 units/ml catalase (Cat).
The MMP was measured as described above. Data are mean ± SEM
of four independent experiments performed in duplicate. *p < 0.05
compared with silibinin alone.
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Figure 5 Role of AIF nuclear translocation in silibinin-induced cell death. (A) Cells were exposed to with 30 μM silibinin for various times
and cytosolic and nuclear fractions were prepared. AIF expression was estimated by Western blot using antibodies specific against AIF. (B) Cells
were exposed to 30 μM silibinin for 36 h in the presence or absence of 0.5 μM calpain inhibitor (CHO). AIF nuclear translocation was estimated
by immunofluorescence using antibody specific against AIF. Nuclei were counterstained with propidium iodide (PI). Images were captured by
confocal microscope and presented. Arrows indicate AIF nuclear localization. (C) Cells were transfected with mipcDNA vector for LacZ or AIF
micro-RNA (mi-AIF). The expression levels of AIF were determined by Western blotting. (D) Cells transfected with LacZ or mi-AIF were exposed
to 30 μM silibinin for 36 h and cell viability was estimated by MTT assay. Data are mean ± SEM of four independent experiments performed in
duplicate. *p < 0.05 compared with LacZ control; #p < 0.05 compared with LacZ silibinin.
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pase-9 activation through Apaf-1. The activated cas-
pase-9 then activates the downstream caspase-3
[26-28]. Mitochondria have also been reported to con-
tain AIF, which can cleave directly DNA and intracel-
lular substrates when released into the cytosol. During
apoptosis, AIF translocates into the nucleus where it
causes oligonucleosomal DNA fragmentation [29,30].
The present study showed that silibinin causes AIF
nuclear translocation, which was inhibited by the cal-
pain inhibitor (Figure 5A and 5B). To determine if sili-
binin induced cell death through AIF nuclear
translocation, effect of silibinin on the cell death in
cells transfected with AIF mi-RNA was measured.
Transfection of AIF mi-RNA was decreased AIF pro-
tein levels (Figure 5C) and effectively prevented the
silibinin-induced cell death (Figure 5D). These data
suggest that calpain activation induces AIF-dependent
cell death in silibinin-treated cells. This is the first
report showing involvement of calpain-dependent AIF
nuclear translocation in the silibinin-induced glioma
cell death.
Conclusion
The present study demonstrated that silibinin induces
apoptosis through AIF nuclear translocation mediated
by a calpain-dependent pathway in U87MG human
glioma cells. This pathway involves PKC activation and
ROS generation. These data suggest that silibinin may
be considered a potential candidate in prevention and
treatment of human malignant gliomas.
List of abbreviations
AIF: apoptosis-inducing factor; DCF: 2’,7’-dichlorofluorescein; DCFH-DA: 2’,7’-
dichlorofluorescein diacetate; DiOC6(3): 3,3’-dihexyloxacarbocyamide; MTT: 3-
[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; PBS: phosphate
buffer solution; PKC: protein kinase C; ROS: reactive oxygen species; △ψm:
mitochondrial membrane potential.
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